Beste Vitamininfusionen Therapeuten - TOP-46 Ärzte

Die medizinische Ästhetik ist ein Spezialgebiet der Medizin, das sich auf die Verbesserung des kosmetischen Erscheinungsbilds durch die Behandlung von Erkrankungen wie Narben, schlaffer Haut, Falten, Muttermalen, Altersflecken, überschüssigem Fett, Cellulite, unerwünschter Behaarung, Hautverfärbungen und Besenreisern konzentriert. In Istanbul, Türkei, umfasst die medizinische Ästhetik eine breite Palette nichtchirurgischer Verfahren, die darauf abzielen, das Aussehen einer Person zu verbessern und ihr Selbstvertrauen zu stärken.

• Injektionen: Einschließlich Botox und Hautfüller, um das Auftreten von Falten zu reduzieren und die Haut aufzupolstern.
• Laserbehandlungen: Werden zur Haarentfernung, Hauterneuerung und zur Verringerung der Sichtbarkeit von Narben oder Pigmentierung eingesetzt.
• Hautverjüngung: Beispielsweise chemische Peelings, Mikronadelung und Lichttherapie zur Verbesserung der Hautstruktur und des Hauttons.

Ausbildung:

1977 - 1984 - Medizinisches Institut, Fachrichtung "Medizinisches Geschäft"

Fähigkeiten verbessern und neues Wissen erwerben:

1990 - Klinische Assistenzzeit im Fachgebiet „Zyklustherapie mit klinischer Kardiologie“, Kiew

1992 - TU „Medizinische Radiologie“, Charkiw

1995 - TU „Moderne Methoden der Diagnostik innerer Erkrankungen und Rheumatologie“, Kiew

1999 - TU „Organisation der medizinischen Unterstützung der Streitkräfte“, Kiew

2004 - TU „Aktuelle Fragen der klinischen Arrhythmologie in der Kardiologie“, Kiew

2009 – TU „Aktuelle Fragen der Therapie und Rheumatologie“, Kiew

2012 - TU „Grundlagen der geriatrischen Wissenschaft“, Kiew

2013 – Institut für Weiterbildung von Führungskräften der Nationalen Akademie der Wissenschaften beim Präsidenten der Ukraine, Kiew

2014 - TU „Aktuelle Fragen der Therapie und Pulmonologie“, Kiew

2016 - Spezialisierung „Organisation und Management der Gesundheitsfürsorge“, Kiew

2018 - TU „Aktuelle Fragen der inneren Erkrankungen des Patienten“, Kiew

2020 - TU „Aktuelle Fragen der Therapie“, Kiew

2021 - TU „Aktuelle Fragen der inneren Erkrankungen des Patienten“, Kiew

2023 - TU „Aktuelle Fragen – Klinische Kardiologie“, Kiew

Die wichtigsten Bereiche der praktischen Tätigkeit:

Untersuchung, Anamnesestudie und Konsultationen zur Behandlung von Krankheiten eines therapeutischen Profils

Termin der erforderlichen Zusatzuntersuchung

Interpretation der Analyseergebnisse

Festlegung eines individuellen Behandlungsplans und Empfehlungen zur Krankheitsprävention

Steuerung von Therapie-, Erholungs- und Rehabilitationsmaßnahmen

Mitarbeit in Verbänden:

Verband der Therapeuten der Ukraine

Verband der Kardiologen der Ukraine

Verband der Gastroenterologen der Ukraine

Organisation der medizinischen Versorgung in EU-Ländern

Verband der Physiotherapeuten („Karlovo Vary“, Prag)

Der Therapeut behandelt folgende Erkrankungen:

SARS

akute Bronchitis

Lungenentzündung

Staatliches öffentliches Unternehmen

akute vasomotorische Rhinitis

chronische Gastroduodenitis

Geschwürkrankheit

chronische Cholezystitis

Pankreatitis

Nicht übertragbare Krankheiten

Hypertonie

Angeborene Herzkrankheit

Gicht

Gichtpolyarthritis

akute Blasenentzündung

Stoffwechselstörungen, Fettleibigkeit

Berufserfahrung:

2017 - 2024: SALTAT CLINIC GÖZTEPE BRANCH, Facharzt für Dermatologie und Venerologie

2014 - 2017: MEMORIAL WELLNESS, Facharzt für Dermatologie und Venerologie

2008 - 2014: PRIVATES ISTANBUL MEDIPOL KRANKENHAUS, Facharzt für Dermatologie und Venerologie

2006 - 2008: MEDICALPARK BAHÇELİEVLER HOSPITAL, Facharzt für Dermatologie und Venerologie

2003 - 2006: TBV SERVICE KRANKENHAUS, Facharzt für Dermatologie und Venerologie

1999 - 2003: FIZIKOM AESTHETICS AND LASER CENTER, Facharzt für Dermatologie und Venerologie

Ausbildung:

1996 - 1999: HASEKI STATE HOSPITAL - Facharztausbildung in Dermatologie

1989 - 1995: Universität Istanbul, Medizinische Fakultät Istanbul, Ausbildung zum Arzt

Veröffentlichte Zeitschriftenartikel, indiziert nach SCI, SSCI und AHCI I. Untersuchung der Wirksamkeit der Teledermatologie bei der Diagnose von Hautläsionen bei pädiatrischen Patienten TaslidereN.,KucukO.S. Revista daAssociacaoMedicaBrasileira (1992),Bd. 69, Nr. 10,2023 (SCI-Erweitert) I. Kann mit der Teledermatologie-Methode eine korrekte Diagnose gestellt werden? TAŞLIDEREN.,SUKÜÇÜKÖ. ACTADERMATOVENEROLOGICACROATICA,Bd. 30, Nr. 1, S. 32–39,2022 (SCI-Erweitert) I I. Durch COVID-19 verursachtes Melkersson-Rosenthal-Syndrom: Ein Fallbericht TaşlıdereB.,MehmetajL.,ÖzcanA.B.,GülenB.,TaşlıdereN. AmericanJournalofEmergencyMedicine, Bd. 41, 2021 (SCI-Expanded) IV. Welche Hautpatienten besuchten während des SARS-CoV-2-Ausbruchs in der Türkei dermatologische Ambulanzen und was geschah mit ihnen? CENGİZ FP, EMİROĞLUN., BAHALIA.G., DİZMAND., TAŞLIDEREN., Akarslan T.C., Gunes B., MERTÖ., KÜÇÜKÖ.S., ONSUNN. DERMATOLOGICTHERAPY, Bd. 33, Nr. 4, 2020 (SCI-Expanded)

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

I was born in Naples, born in 1981, and I have the best job in the world. Imagine waking up every morning and knowing that on that day you will make someone's dream come true: you will change a man's life forever, you will give birth to a new woman, you will help a girl achieve happiness, a boy gain self-confidence. I am Silvio Ascione, specialist in Plastic, Reconstructive and Aesthetic Surgery. Son of art, from my father, a great man and great plastic surgeon, I learned the complex and enchanting magic of aesthetic plastic surgery. Nourished by art and medical knowledge, I grew up in operating theatres, always behind my father's back who, like the best of masters, passed on to me, a young disciple, the passion for a profession in which art combines to science to create masterpieces. Graduated in Medicine and Surgery in 2005 from the Second University of Naples, qualified in the first session of 2006 and specialized in Plastic, Reconstructive and Aesthetic Surgery at the School of Specialization of the Second University of Naples directed by Prof. Francesco D'Andrea, I am enrolled in the 'Order of Surgeons of Benevento and I obtained a Master's degree in Oncoplastic Surgery and integrated treatments at the University of Genoa.

My experience in the surgical room, however, began much earlier, and it was an intense, very hard journey, characterized by total dedication, constant updating, continuous training: initially internal at the Department of Plastic, Reconstructive and Aesthetic Surgery of the S.U.N., I frequented then the Department of Reconstructive and Aesthetic Plastic Surgery of the Mediterranean Clinic of Naples affiliated with the “Tor Vergata” University of Rome, the A.O.R.N. Major Burns Center Department, directed by Prof. Roberto D'Alessio, the Trauma Center Department of Prof. Antonio Martin.

I regularly participate in all the main national and international Plastic Surgery conferences to stay constantly updated on the technological innovations offered by the market, the cutting-edge products and instruments to be used for my treatments, the new research and the most recent studies in the field of plastic and aesthetic surgery.

I studied and carried out in-depth internships at universities and hospital centers in Spain, France and North America, gaining extraordinary experience on the most advanced surgical techniques, in particular on facial and breast rejuvenation.

​

MY MISSION

My innate passion for surgery, my attention to the care of the image and the harmony of forms, my obsessive precision and attention to detail, my unstoppable research and updating activity, my decades of experience in the most varied spheres of plastic and aesthetic surgery, working side by side with my specialized team, allow me today to boast a curriculum full of successes and satisfactions and to be able to offer my patients a detailed and scrupulous visit, a precise diagnosis, a treatment plan personalized and efficient intervention, agreed on the basis of the patient's needs and desires, highly effective personal techniques and tools to eliminate all types of blemishes, signs of aging or congenital imperfections, through increasingly less invasive interventions and with increasingly natural results.

​

Experience, professionalism, harmony, naturalness: these are the four key points on which I build a relationship that is first human, then professional, with my patient. The choice of plastic or aesthetic surgery does not only involve the decision to undertake a path of external change. For this reason I dedicate myself with dedication and attention to listening to the discomforts and wishes of each of my patients, so that we can plan together the most appropriate intervention for their needs and to achieve the expected result and to accompany them step by step towards a path of external and internal rebirth

Anesthesiologist - Colombia

Pain Medicine Specialist - Colombia

Mg. in advanced pain management- Spain

Certified in Stem Cells applications by ISSCA. 

Certified meditation teacher based on kindness and compassion- Spain

Mg. in precision medicine - Spain

Diploma in Orthomolecular Medicine. FUCS 2023

International Online Workshop in Allogenic Cellular Based Products for Regenerative Medicine. International Society For Stem Cell Application ISSCA (10/28/2023)

Certification of point of care regenerative medicine. International society for stem cell application ISSCA. Endorsed by Marmara University. (Nov 03-05 2023). Cancun, Mexico. Registration number 8229.

Member of International Society for Stem Cell Application (ISSCA) - Mexico (2023)

Workshop on the use of Stem Cells and Ozone for degenerative disc disease (Regenerative Medicine in the Spine) - Lima - Peru. (April 2024)

Functional and Integrative Doctor - Colombia, USA. (2018)

Rejuvenate Beauty with Konarc Aesthetics Cosmetic Surgery in Gurgaon, India

For those battling with insecurities about their appearance, cosmetic surgery offers a transformative solution. Dr. Preeti Yadav at Konarc Aesthetics, a seasoned plastic surgeon with over a decade of experience in aesthetics, leads a renowned clinic in Gurgaon, India. Her approach is holistic, catering to each patient's unique needs and desires.

As a female plastic surgeon, Dr. Preeti Yadav understands the specific concerns that women face regarding their bodies. From mothers seeking post-childbirth recovery to teenagers grappling with body image issues, Dr. Yadav empathetically listens to her patients' worries and provides sustainable solutions.

The clinic specializes in a range of procedures tailored to enhance beauty and confidence. Popular treatments include rhinoplasty, jawline shaping, chin enhancement, cheek augmentation, lip fillers, arm and back liposuction, bust surgeries (reduction/enlargement/lift), tummy and waist sculpting, buttock lifts, vaginal rejuvenation, and thigh lifts.

Treatments and Procedures

• Hair Transplant
• Liposuction
• Breast reshaping
• Facial plastic surgery
• Laser therapy
• Male breast surgery
• Reconstructive surgery
• Surgical and non-surgical weight loss procedures
• Non-surgical treatments like botox and fillers

More Information you can contact to us.

• Spezialisiert auf Haartransplantation mit DHI-Technik.
• Sprecher von Hansbiomed Thailand
• Ausbilder für einen Haartransplantations-Schulungskurs für andere Ärzte an der MP Academy.
• Ausbilder im Advanced Filler-Schulungskurs für andere Ärzte an der MP Academy.
• Gründer und Direktor der MP Clinic
• Gründer der One Bright Clinic Chiangmai
• Gründer der MP Clinic Chiangmai
• Gründer der Morepure Clinic Phuket
• Geschäftsführer der MP Clinic
• Finanzvorstand der MP Clinic
• Chief Marketing Officer der MP Clinic
• Chief Operating Officer der MP Clinic

Dr. Alex Aesthetic Clinic is an aesthetic surgery clinic that has a reputation and standard in the plastic surgery industry for over 10 years. The celebrities are well known. They are very much talked about because Dr. Alex has spent his past work in famous aesthetic surgery clinics in Bangkok until he had the opportunity to open the clinic in Doctor Alex’s hometown (Chiang Mai). The doctor’s attitude is focused on quality under the concept of “Quality is our Best Priority” with the principle of “A Quality You can Trust”

Dr. Alex Aesthetic Clinic has launched an aesthetic surgery clinic in Chiang Mai province recently. Initially, the first branch in Bangkok, about ten years and later expanding in Chiang Mai, with Dr. Anek Sony, which is a doctor, executive, and managing director of the clinic.

Doctor Alex. An aesthetic surgery doctor who devoted most of his work and time to creating facial art and the patient’s body through the blade and needle. A doctor’s ideal, anything that requires a knife, must be used, but use requires art and knowledge. Otherwise, the work will be disastrous.

Dr. Alex has a Doctor of Medicine from Chiang Mai University. He has accumulated working experience from leading clinics and other hospitals both in Thailand and abroad. After that, he had the opportunity to study in Anti-Aging and Regenerative medicine MS from Mae Fah Luang University.

Until he was receiving the American Board of Anti-Aging and Regenerative Medicine, after that, the doctor is going to study at Regenerative Medicine in Arizona, USA. Until returning to Thailand. Dr. Alex brings the perfect combination of the science of solving problems by methods of In Side Out and Out Side In to apply. Moreover, Dr.Alex has the opportunity to study aesthetic surgery in many countries such as the USA, Germany, England, Italy and also study complicated surgery such as endoscopic surgery, using Laser (Israel) in surgery to achieve a unique working style.

Creating beauty on the face and body. The important thing is “Patient satisfaction not only the satisfaction of the doctor.”

The experience was the beginning of the Dr. ALEX Aesthetic and Regenerator Clinic for Chiang Mai people. Whether celebrity, net Idol, model, and Thai and foreign customers all over the country who trust to look after.

Dr. Alex Aesthetic Clinic is located on Tha pae Road in the center of Chiang Mai. In the future, Dr. Alex has the concept and vision to develop the beauty business to become the first and certified with high standards surgery hospital in the north.

Dermatologist

Regular member of the Korean Dermatological Society

Regular member of the Korean Dermatological Association

Regular member of the Korean Laser Society

Regular member of the Korean Society of Dermatological and Aesthetic Surgery

Former) Director of Oracle Dermatology Apgujeong Branch

Current) Director of Oracle Dermatology Cheongdam branch

Name: Zeynep Betul

Surname: Tatac

Birth date: 1986

Medical Doctor and Consultant

Medical Faculty Graduation: Hacettepe University Medical Faculty (2004-2010)

Specialization in Mesotherapy 

Fillers and Botox course

Certification of Acupuncture

Certification of Ozone Therapy

Certification of Cupping Therapy

Wellness and Longevity Course

Functional Medicine Course

Iv therapies and anti-oxidan therapies

Anti-aging therapies

Check-up an diagnostic services

City: Antalya

Country: Turkey

Hello, I am Fatma Duha Özkılıç. I was born in Antalya in 1994. I completed my undergraduate studies in Health Vocational High School Nursing studies between 2008-2012 and Ankara Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation between 2015-2019. I was developed by obtaining various certifications such as Manual Therapy Training, Norton School International Lymphedema Certification and Pelvic Floor Physiotherapy Training. Throughout my career, I have discovered the only principle of continuous improvement in the expanding spectrum of education. I have in my body the hard work, theoretical and practical knowledge required in every field of the health sector, the ability of teams, the ability to empathize and many more. My main goals are to minimize the pain and suffering that people experience due to their diseases and to improve their quality of life. Being involved in the improvements of the treatment process increases my commitment to the profession. I think that I will contribute to my profession with my devoted efforts in dealing with patients, whether they are treated or not.

Dr. Patty is the newest addition to the team. She graduated with a medical degree from the joint program between the University of Nottingham and Srinakharinwirot University.

Dr. Patty has been working passionately on aesthetic and anti-aging fields, focusing on both pre-rejuvenation and rejuvenation.

Internationally Certified Aesthetic doctor, aims to preserve youth and good health along with special interest in giving you the confidence from within.

After graduating with a Medical Degree from Thammasat University, Dr. Chayut worked as an Intern in a Public Hospital for a year’s residency.

For the next 6 years, he found his calling in Aesthetic Medicine Dr. Diacakis has performed enhancement procedures since 2001, and in fact, has been credited as one of the pioneers.

Dr. Chayut and Dr. Diacakis met in 2014 at an Aesthetic Congress in Paris France. He has experience in many procedures such as rhinoplasty, anaplasty, mentoplasty, blepharoplasty, lip reduction, buccal fat removal, and enhancement.

DR. Arzu Musaeva

Education: Azerbaijan Medical University.

Specialization: therapist

Working hours and days: weekdays 10:00-15:00.

Training and membership:

16.02-31.03.2000 thematic development of the cycle “Current issues of infectious diseases”.

02.01-15.02.2001 thematic cycle “Clinical pharmacotherapy of internal diseases”.

improvement.

01-30.12.2005 thematic improvement in the course “Chronic renal failure”.

22.11-27.12.2005 "Applied Homotoxicology" (56 hours) prof. Safihan Gasanov.

26-30.01.2006 "Applied Homotoxicology" (36 hours) Dr. Klaus Kuestermann (Baden-Baden,

Germany).

12-24.11.2006 "Applied Homotoxicology" (48 hours) Doctor of Technical Sciences Elena Nekrasova

23-28.04.2007 "Homeoisopathy" Dr. Burkhard Flechsig.

28.05-02.06.2007 "Sanum Therapy" Dr. Anita Krake (Germany).

13.12. 2008. “Microbiological Therapy” Doctor of Medical Sciences Michael Schreiber (Germany).

14-18.03.2008 "Module B" Dr. Marion Krasnitzer-Geyer, Dr. med. Siddhartha Popat (Baden-

Baden, Germany).

20-22.06.2008. "Acupuncture and Homeosiniatry" Dr. med. Siddhartha Popat (Baden-Baden,

Germany).

27-29.11.2009. "Introduction to Homeosiniatry" Dr. med. Joachim Bandlow.

02/16/2010. "Homotoxicology" Dr. Alta Smith.

05-09.11.2010. Course "Applied Homotoxicology" (36 hours). Dr. med. Burkhard Flechsig, Dr. med.

Joachim Bandlow.

21-22. 01.2011. "Introduction to Isopathy and Sanum Therapy". Med. Thomas Rau.

04.04.2011. "Microbiological Therapy" Dr. Kerstin Rasch, Dr. Volker Rusch.

10.20.2013. "Traditional medicine with biological medicine in diseases of the endocrinological and lymphatic systems"

"Sharing Methods" by Dr. Jurgen Frost.

07.04-02.05.2014 "Azerbaijan State Medical Institute named after A.Aliyev"

refresher course.

11/12/2014. "Inflammation: A New Concept" by Dr. Alta Smith.

10-11.04.2015. "Diabetes, Stress and Associated Diseases" Dr. med. Siddhartha Popat

(Baden-Baden, Germany).

12-16.05.2015. "Neurology, autoimmune diseases" Dr. of Medical Sciences Thomas Rau (Switzerland).

05/28/2015. "Basics of acid-base balance" "Hormones and health" Dr. med. Burkhard

Flechsig (Germany).

10.21.2015. "Fundamentals of Oncology" by Dr. Gerhard Reiss (Germany).

12/21/2015. "Mesotherapy" Dr. Alta Smith (Germany).

01-03.04.2016. Dr. "Allergy, Inflammation, Stress". Bert Hannosset (Germany).

05/28-29/2016 “Aesthetic Medicine” Dr. Tatiana Rivkina (Italy).

06/13-14/2016 “Fibromyalgia, Gout, Psoriasis” Dr. med. Gerhard Reis (Germany).

04-08.10.2016. "Mucosa Syndrome" Dr. Arturo Obirne (Colombia).

21.10. 2016. "Microbiological Therapy" by Dr. Uwe Peters (Germany).

31.10-01.11.2016. "Thyroid depletion syndrome" Dr. Gerhard Reiss (Germany).

10-11.11.2017. "Microbiological therapy – the basis of regulation" Dr. Uwe Peters (Germany).

12.2017. "Neurotherapy and Homotoxicology" Dr. med. Siddhartha Popat (Baden-Baden,

Germany).

2017. "Metabolic Syndrome" Dr. med. Annette Jaensch.

2017. "Healthy Aging, Proven Remedies in Integrative Medicine", Dr. Ralf Ottmaier

(Switzerland).

14-20.05.2018. "From segment to barrier, nutrition and inflammation, vitamin C and diabetes", doctor.

honey. Arturo Obirne (Colombia).

15-17.11.2018 "Elimination Therapy Methods, Success in Old Age" Dr. Marion Krasnitzer-Geyer

(Baden-Baden, Germany).

04.2018. "Bioregulatory treatment of chronic infections" Dr.rer.nat. Petra Grüning.

21-23.09.2018. "Possibilities of treating degenerative diseases using systemic bioregulatory medicine"

Doctor med. Siddhartha Popat (Baden-Baden, Germany).

01/25/2019. "Basics of mistletoe therapy with Helixor and its application in practice" Doctor of Medical Sciences Christfried

Preussler (Germany).

05/11/2019 “Mesotherapy” Dr. Nicoletta Frasca

05/14/2019. "Sanum Therapy for Liver Diseases" by Dr. Dieter Sonntag

06.04.2019. "Isn't fatigue the call of the liver?" Dr. Petra Grüning.

14-19.10.2019. "Bioregulatory treatment of dermatological diseases". med. Arturo Obirne

(Colombia).

Based on the results of successful treatment of trophic ulcers of various origins with biological preparations

Received the Hans-Heinrich Reckeweg Prize for clinical cases.

Examinations and treatment performed:

• Bioregulatory therapy of all therapeutic diseases.

• Atherosclerosis, stenosis, occlusion of peripheral arteries.

• Varicose veins, thrombophlebitis, thrombosis, lymphostasis of peripheral veins.

• Peripheral nerve neuropathy.

• Diabetic paw, osteoarthropathy, osteomyelitis.

• Detoxification and bioregulation of blood glucose at the cellular level. Diabetes mellitus

treatment and prevention of delayed complications in the lower extremities.

• Gangrenous pyoderma.

• Treatment of trophic ulcers.